Evans Caroline A CA

Previous page
1 / 2
You're on page 1
page 2
Next page

Sort by:

Relevance

Page size

A normalization method to decipher quantitative proteome changes in microbial co-culture systems

The value of synthetic microbial communities in biotechnology is gaining traction due to their ability to undertake more complex metabolic tasks than monocultures. However, a thorough understanding of strain interactions, productivity and stability is often required to optimize growth and scale up c...

ORGANISM(S): Synechococcus Elongatus Pcc 7942 = Fachb-805 Azotobacter Vinelandii Dj

2024-01-13 | PXD046627 |

Quantitative proteomic analysis reveals maturation as a mechanism underlying glucocorticoid resistance in B lineage ALL and JNK inhibitors as a re-sensitising therapy

Glucocorticoids (GC) are pivotal in the treatment of childhood acute lymphoblastic leukaemia (ALL) but resistance is a continuing clinical problem with the underlying mechanisms still unclear. An isobaric tag proteomic approach was used to compare protein profiles of the B lineage ALL GC-sensitive c...

ORGANISM(S): Homo sapiens

2015-09-02 | E-GEOD-63335 | biostudies-arrayexpress

Expression Analysis of Mammary Epithelial Cells Isolated from 12-16 Week Old Virgin C57Bl6 Lrp5+/+ and Lrp5-/- Mice

Investigation of whole-genome gene expression level changes in C57Bl6 Lrp5-/- mammary epithelial cells, compared to the wild-type strain. The mammary epithelial cells were isolated from numbers 4 and 5 mammary glands. The Lrp5-/- mouse strain described in this study has been further described in Lin...

ORGANISM(S): Mus musculus

2010-05-19 | E-GEOD-19228 | biostudies-arrayexpress

Early short course of neuromuscular blocking agents in patients with COVID-19 ARDS: a propensity score analysis.

Not available

S-EPMC9112652 | biostudies-literature

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8598213 | biostudies-literature

Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.

Not available

S-EPMC8084355 | biostudies-literature

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis.